The Latest Available Economic and Activity Data on Biotechnology and Innovation
Jul 27th, 2009 | By French BioBeach | Category: Biotech and Pharma in France, Latests News and AlertsResearch and Markets has announced the addition of the “Biotechnology Statistics Almanac – 2009” report to their offering.
Biotechnology Statistics – 2009 edition brings together the latest available economic and activity data on biotechnology and innovation. T
The survey data provide results on the number of biotechnology firms, business expenditures on R&D, biotechnology employment, and sales of biotechnology goods and services.
Countries Covered:
Australia, Austria, Belgium, Canada, the Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Korea, Luxembourg, Mexico, the Netherlands, New Zealand, Norway, Poland, Portugal, the Slovak Republic, Spain, Sweden, Switzerland, Turkey, the United Kingdom and the United States.
Key Topics Covered:
1 World Biotechnology, 2009
2 World Biotechnology Companies, 2009
3 Research and Development Expenditure in Biotechnology Sector
4 Employment Sector in Biotechnology Industry
5 Total Sales in Biotechnology Industry
6 Market of Biotechnology by Application Areas
7 Patents in Biotechnology Industry
8 Biotechnology in Agriculture Sector
9 Biotechnology in Healthcare Sector
10 Biotechnology in Industrial Sector
11 Mergers and Acquisitions in Biotechnology Industry
12 Venture Capital Investment in Biotechnology Industry
For more information visit http://www.researchandmarkets.com/research/70a100/biotechnology_stat
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax (USA): 646-607-1907
Fax (International): +353-1-481-1716
Related posts:
- France Set To Lead The Growth Of The European Active Pharmaceuticals Ingredients Market
- Marie Curie International Research Staff Exchange Scheme (IRSES)
- 2009 French-American Innovation Day – Call For Project – $300K Competition
- Biotechnology Training For Stem Cell Related Jobs
- “Cord Blood and Adult Stem Cells for biotechnology and regenerative medicine”